Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease
Author:
Publisher
American Thoracic Society
Subject
Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine
Reference107 articles.
1. Characterisation of COPD heterogeneity in the ECLIPSE cohort
2. The path to personalised medicine in COPD
3. Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management
4. Chronic Obstructive Pulmonary Disease Phenotypes
5. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
Cited by 71 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Identification of two hub genes and miRNA‑mRNA interactions in chronic obstructive pulmonary disease (COPD) plasma;Journal of Asthma;2024-03-07
2. A Macrophage-Related Gene Signature for Identifying COPD Based on Bioinformatics and ex vivo Experiments;Journal of Inflammation Research;2023-11
3. Can Treatable Traits Be the Approach to Addressing the Complexity and Heterogeneity of COPD?;International Journal of Chronic Obstructive Pulmonary Disease;2023-09
4. GOLD 2023 streamlines pharmacological treatment;European Respiratory Journal;2023-09
5. An Update on Outcomes for COPD Pharmacological Trials: A COPD Investigators Report - Reassessment of the 2008 American Thoracic Society/European Respiratory Society Statement on Outcomes for COPD Pharmacological Trials;American Journal of Respiratory and Critical Care Medicine;2023-08-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3